Why the study?
Does intracoronary BQ-123 prevent the normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty in patients undergoing coronary angioplasty?
Does intracoronary BQ-123 prevent the normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty in patients undergoing coronary angioplasty?
Acute ET(A) receptor antagonism with BQ-123 prevents the normal ischemic preconditioning-like reduction of myocardial ischemia during repeated balloon inflations, possibly due to a coronary collateral steal effect.
Answers are grounded in this paper and cite their sources.
BQ-123 blunts ischemic preconditioning during PCI; challenges ET(A) antagonism for periprocedural protection and leaves clinical outcomes open.
BACKGROUND: Myocardial ischemia and reperfusion are associated with increased production of endothelin (ET)-1. METHODS AND RESULTS: We examined the effects of BQ-123, a selective ET(A) receptor antagonist, in 80 patients. All patients were randomly allocated to an intracoronary infusion of saline or BQ-123 (6 micromol/L over 20 minutes). The reference group consisted of 20 patients undergoing coronary angiography. BQ-123 produced a 10% (P:<0.005) increase in distal coronary artery diameter. The main study group consisted of 30 patients undergoing coronary angioplasty. All patients underwent a minimum of 3 balloon inflations (BIs). Surface and intracoronary electrocardiographic ST-segment shift as well as pain score were recorded at the end of each BI. BQ-123 or saline was given by intracoronary infusion between the second and the third BI in random allocation. In the saline group, intracoronary ST-elevation decreased from 1.26+/-0.55 mV during the first BI to 0.77+/-0.56 mV during the third BI (P:<0.05) and the surface ST elevation decreased from 0.20+/-0.15 to 0.10+/-0.07 mV (P:<0.05). In the BQ-123 group, the respective values were 1.22+/-0.48 mV and 1.13+/-0.62 mV (intracoronary) and 0.17+/-0.18 and 0.17+/-0.21 mV (surface) (both P:=NS). The decrease in pain score was significantly higher in the saline group (F:=5.97, P:=0.004). In 30 patients (collateral circulation group), the angioplasty protocol was repeated with the use of a pressure guide wire. BQ-123 produced a significant (F:=3.30, P:=0.04) decrease in coronary wedge pressure. CONCLUSIONS: Acute ET(A) receptor antagonism prevents the normal reduction of myocardial ischemia on repeated BIs during angioplasty. This may be explained by a "steal" effect through coronary collaterals.
No takes yet. Share an insight, caveat, or question.
Kyriakides et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: